Amgen sales and marketing update

Amgen launched leukemia drug Blincyto blinatumomab. Blincyto has a wholesale acquisition cost (WAC) of $3,178.57 per single-use vial, or $89,000 for a 28-day treatment cycle, in which 9 µg/day is giv...